Zobrazeno 1 - 10
of 19
pro vyhledávání: '"José Ramón Azanza Perea"'
Autor:
José Ramón Azanza Perea
Publikováno v:
Revista Iberoamericana de Micología. 38:52-55
Liposomal amphotericin B is a lipid formulation of the antifungal drug amphotericin B with some distinguishing characteristics in its pharmacological behavior that entail some clinical differences of great interest. The significant improvement in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51e5e5db0cb5a0016103dc6c416177bc
https://doi.org/10.1016/j.riam.2021.02.004
https://doi.org/10.1016/j.riam.2021.02.004
Autor:
José Ramón, Azanza Perea
Publikováno v:
Revista iberoamericana de micologia. 38(2)
Liposomal amphotericin B is a lipid formulation of the antifungal drug amphotericin B with some distinguishing characteristics in its pharmacological behavior that entail some clinical differences of great interest. The significant improvement in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1859b984f952fbd465d4ef1426cf6005
https://pubmed.ncbi.nlm.nih.gov/33992527
https://pubmed.ncbi.nlm.nih.gov/33992527
Publikováno v:
Revista Iberoamericana de Micología. 35:186-191
Isavuconazole is a new azole, structurally related to fluconazole and voriconazole, that presents a very high oral absorption with no first-pass effect which is not interfered by the presence of food, gastric pH modifications, or mucositis. Its distr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ddb140f5aba36e2fdaf348214533533
https://doi.org/10.1016/j.riam.2018.04.003
https://doi.org/10.1016/j.riam.2018.04.003
Autor:
José Ramón Azanza Perea
Publikováno v:
Revista Iberoamericana de Micología. 33:140-144
The echinocandins share pharmacodynamic properties, although there are some interesting differences in their pharmacokinetic behaviour in the clinical practice. They are not absorbed by the oral route. They have a somewhat special distribution in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3daac7264b1c662c319feaf40bb7a854
https://doi.org/10.1016/j.riam.2016.02.004
https://doi.org/10.1016/j.riam.2016.02.004
Publikováno v:
Revista iberoamericana de micologia. 35(4)
Isavuconazole is a new azole, structurally related to fluconazole and voriconazole, that presents a very high oral absorption with no first-pass effect which is not interfered by the presence of food, gastric pH modifications, or mucositis. Its distr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0678738a9ff02cfa65bcbb5eb3bbc151
https://pubmed.ncbi.nlm.nih.gov/30477963
https://pubmed.ncbi.nlm.nih.gov/30477963
Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
There are 5 BCR/ABL tyrosine kinase inhibitors (TKIs) for the treatment of chronic myeloid leukemia (CML): bosutinib, ponatinib, imatinib, nilotinib and dasatinib. The availability of several therapeutic options raises the possibility of individualiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22769704e6b9e53ffc73c82fe584ee3f
https://hdl.handle.net/10171/64793
https://hdl.handle.net/10171/64793
Publikováno v:
PharmacoEconomics Spanish Research Articles. 4:97-107
Objetivo: La creciente importancia de la evaluacion economica como herramienta para recomendar o rechazar la adopcion de determinadas tecnologias sanitarias subraya la necesidad de definir un umbral de coste-efectividad en Espana. Una revision de las
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfac67b28448d4a1598a0f85df8c6782
https://doi.org/10.1007/bf03320930
https://doi.org/10.1007/bf03320930
Autor:
José Ramón, Azanza Perea
Publikováno v:
Revista iberoamericana de micologia. 33(3)
The echinocandins share pharmacodynamic properties, although there are some interesting differences in their pharmacokinetic behaviour in the clinical practice. They are not absorbed by the oral route. They have a somewhat special distribution in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f06af58c96d8299a8c16e190fd6b8c7
https://pubmed.ncbi.nlm.nih.gov/27395024
https://pubmed.ncbi.nlm.nih.gov/27395024
Autor:
José Ramón Azanza-Perea, Jesús Honorato-Pérez, Belén Sádaba-Díaz de Rada, Emilio García-Quetglas
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 24:546-550
Introduccion El tratamiento de las infecciones urinarias del tracto inferior no complicadas se realiza con pautas de tratamiento cortas. En otras circunstancias no esta tan clara la pauta que hay que seguir. Cuando la infeccion urinaria del tracto in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e65e987bb80b7e12a452a733438b672
https://doi.org/10.1157/13093873
https://doi.org/10.1157/13093873
Publikováno v:
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 25(1)
Amphotericin B in its lipid formulation continues to be the reference drug in the treatment of systemic fungal infections despite the time elapse since the development of this compound. The absence of fungal resistance, pharmacokinetics, and the bett
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f72e8fd7d3611b6b6d4cb1092d414787
https://pubmed.ncbi.nlm.nih.gov/22488537
https://pubmed.ncbi.nlm.nih.gov/22488537